KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
Sehhoon Park, Ji-Yeon Kim, Se-Hoon Lee, Beomseok Suh, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Korean J Intern Med. 2017;32(3):514-522.   Published online 2017 Apr 14     DOI: https://doi.org/10.3904/kjim.2015.299
Citations to this article as recorded by Crossref logo
Realities of KRAS-mutated non-small cell lung cancer
Young Joo Min
The Korean Journal of Internal Medicine.2017; 32(3): 442.     CrossRef